In DKA management, why must potassium be ≥3.3 mEq/L before initiating IV insulin therapy?

• A. Insulin drives potassium into cells and can cause dangerous hypokalemia.
• B. Potassium level is not relevant to insulin therapy.
• C. Potassium must be ≥5.0 to prevent hyperkalemia.
• D. Low potassium enhances insulin efficacy.

Answer: (A)

The important idea is that starting IV insulin in DKA can cause a rapid drop in serum potassium because insulin drives potassium into cells. In DKA, total body potassium is actually depleted from urinary losses and shifts due to insulin deficiency, even if the initial serum potassium is normal or high. When insulin is given, it activates Na+/K+ ATPase, pulling potassium from the extracellular space into cells. If the serum potassium is already low—below 3.3 mEq/L—this intracellular shift can plunge potassium further, leading to dangerous hypokalemia and potentially life-threatening arrhythmias. Therefore, you need to raise serum potassium to at least 3.3 mEq/L with potassium replacement before starting IV insulin, and continue monitoring and adjusting potassium during therapy to keep levels in the safe range.